Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial
- PMID: 20151799
- DOI: 10.1902/jop.2009.090429
Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial
Abstract
Background: Periodontitis is an inflammatory disease that results in bone resorption creating bony defects, which may cause tooth loss. Various drugs have been studied using local delivery to improve the periodontal health and to achieve periodontal regeneration. Simvastatin (SMV) is a specific competitive inhibitor of 3-hydroxy-2-methyl-glutaryl coenzyme A reductase. The present study was designed to investigate the effectiveness of SMV, 1.2 mg, in an indigenously prepared biodegradable controlled-release gel as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis.
Methods: Sixty patients were categorized into two treatment groups: SRP plus placebo (group 1) and SRP plus SMV, 1.2 mg (group 2). Clinical parameters were recorded at baseline before SRP and at 1, 2, 4, and 6 months; they included modified sulcus bleeding index (mSBI), probing depth (PD), and clinical attachment level (CAL). At baseline and after 6 months, radiologic assessment of intrabony defect (IBD) fill was done using computer-aided software. The mean concentration of SMV in gingival crevicular fluid was estimated by reverse-phase high-performance liquid chromatography.
Results: All subjects tolerated the drug, without any postapplication inflammation. Both therapies resulted in significant improvements. The decrease in mSBI score at 6 months was greater in group 2 (2.3267 +/- 0.8017) compared to group 1 (0.5033 +/- 0.6815). The mean decrease in PD from baseline to 6 months was 1.20 +/- 1.24 mm and 4.26 +/- 1.59 mm in groups 1 and 2, respectively. Mean CAL gain from baseline to 6 months was 1.63 +/- 1.99 mm and 4.36 +/- 1.92 mm in groups 1 and 2, respectively. In group 2, there was greater decrease in mean IBD (1.41 +/- 0.74 mm or 32.54%) compared to group 1 (0.09 +/- 0.58 mm or 2.16%).
Conclusion: There was a greater decrease in gingival index and PD and more CAL gain with significant IBD fill at sites treated with SRP plus locally delivered SMV in patients with chronic periodontitis.
Similar articles
-
Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial.J Periodontol. 2013 Jan;84(1):24-31. doi: 10.1902/jop.2012.110721. Epub 2012 Mar 16. J Periodontol. 2013. PMID: 22420871 Clinical Trial.
-
Efficacy of locally delivered 1.2% rosuvastatin gel to non-surgical treatment of patients with chronic periodontitis: a randomized, placebo-controlled clinical trial.J Periodontol. 2015 Jun;86(6):738-45. doi: 10.1902/jop.2015.140631. Epub 2015 Mar 19. J Periodontol. 2015. PMID: 25786565 Clinical Trial.
-
Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial.Aust Dent J. 2013 Jun;58(2):156-62. doi: 10.1111/adj.12042. Aust Dent J. 2013. PMID: 23713634 Clinical Trial.
-
Efficacy of statin delivery as an adjunct to scaling and root planing in the treatment of chronic periodontitis: A meta-analysis.J Investig Clin Dent. 2018 May;9(2):e12304. doi: 10.1111/jicd.12304. Epub 2017 Nov 9. J Investig Clin Dent. 2018. PMID: 29119729 Review.
-
Locally applied statins as adjuvants to non-surgical periodontal treatment for chronic periodontitis: a systematic review and meta-analysis.Clin Oral Investig. 2018 Sep;22(7):2413-2430. doi: 10.1007/s00784-018-2507-x. Epub 2018 Jun 12. Clin Oral Investig. 2018. PMID: 29948277
Cited by
-
Development of transmucosal patch loaded with anesthetic and analgesic for dental procedures and in vivo evaluation.Int J Nanomedicine. 2016 Jun 20;11:2901-20. doi: 10.2147/IJN.S94658. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27382279 Free PMC article.
-
Identification of Genes Differentially Expressed in Simvastatin-Induced Alveolar Bone Formation.JBMR Plus. 2019 Jan 2;3(5):e10122. doi: 10.1002/jbm4.10122. eCollection 2019 May. JBMR Plus. 2019. PMID: 31131344 Free PMC article.
-
Lipid-lowering agents use and systemic and oral inflammation in overweight or obese adult Puerto Ricans: the San Juan Overweight Adults Longitudinal Study (SOALS).J Clin Periodontol. 2015 Dec;42(12):1090-6. doi: 10.1111/jcpe.12461. Epub 2015 Dec 11. J Clin Periodontol. 2015. PMID: 26407668 Free PMC article.
-
Controlled release devices as adjuvants in nonsurgical periodontal therapy: A systematic review.J Indian Soc Periodontol. 2023 May-Jun;27(3):251-261. doi: 10.4103/jisp.jisp_50_22. Epub 2023 May 1. J Indian Soc Periodontol. 2023. PMID: 37346851 Free PMC article. Review.
-
Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers.ISRN Dent. 2011;2011:125168. doi: 10.5402/2011/125168. Epub 2011 Nov 16. ISRN Dent. 2011. PMID: 22203908 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical